Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients

Clinical trial NCT07314294 · RECRUITING

Trial details

NCT number: NCT07314294
Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2025-12-18
Primary completion: 2027-12-30
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.